郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.

期刊：Synapse (New York, N.Y.)发表年份：2006作者：Jeffrey C Glennon; Guus Van Scharrenburg; Eric Ronken; Mayke B Hesselink; Jan-Hendrik Reinders; Martina Van Der Neut; Stephen K Long; Rolf W Feenstra; Andrew C McCreary
阅读更多 →

药效评价MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.

期刊：European journal of pharmacology发表年份：2006作者：Cecilia Cialdai; Manuela Tramontana; Riccardo Patacchini; Alessandro Lecci; Claudio Catalani; Rose-Marie Catalioto; Stefania Meini; Claudio Valenti; Maria Altamura; Sandro Giuliani; Carlo Alberto Maggi
阅读更多 →

药效评价Hepatocellular toxicity and pharmacological effect of amiodarone and amiodarone derivatives.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2006作者：Katri Maria Waldhauser; Michael Török; Huy-Riem Ha; Urs Thomet; Daniel Konrad; Karin Brecht; Ferenc Follath; Stephan Krähenbühl
阅读更多 →

药效评价Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.

期刊：European journal of pharmacology发表年份：2006作者：Katsuya Harada; Masaki Aota; Tatsuo Inoue; Ritsuko Matsuda; Takuma Mihara; Takayuki Yamaji; Koji Ishibashi; Nobuya Matsuoka
阅读更多 →